Patterns of Care in Medical Oncology
How many times have you started a breast cancer patient on adjuvant trastuzumab?
When utilizing adjuvant trastuzumab in breast cancer patients, what adjuvant chemotherapy regimen do you generally use?
Patients with HER2-positive, node-negative breast cancers less than 1 cm should generally receive adjuvant trastuzumab/
chemotherapy as part of their treatment.
Patients with ER-positive, HER2-positive, node-negative, 1-2-cm breast cancers should generally receive adjuvant trastuzumab/
chemotherapy as part of their treatment.
Patients with ER-negative, HER2-positive, node-negative, 1-2-cm breast cancers should generally receive adjuvant trastuzumab/
chemotherapy as part of their treatment.
Adjuvant trastuzumab should generally be started concurrently with chemotherapy rather than sequentially.
Trastuzumab monotherapy is a reasonable nonprotocol adjuvant treatment option in breast cancer patients who are unable to receive chemotherapy
Dose-dense AC
paclitaxel/trastuzumab is a reasonable nonprotocol adjuvant treatment option for breast cancer patients with HER2-positive disease.
Which therapy would you most likely recommend to a breast cancer patient with the following characteristics?
Which therapy would you most likely recommend to a breast cancer patient with the following characteristics?
Which therapy would you most likely recommend to a breast cancer patient with the following characteristics?
Which therapy would you most likely recommend to a breast cancer patient with the following characteristics?
If recommending trastuzumab, which duration of trastuzumab treatment would you use?
If recommending trastuzumab, which duration of trastuzumab treatment would you use?
If recommending trastuzumab, which duration of trastuzumab treatment would you use?
If recommending trastuzumab, which duration of trastuzumab treatment would you use?
If recommending trastuzumab plus chemotherapy, would you most likely start the trastuzumab during or after chemotherapy?
If recommending trastuzumab plus chemotherapy, would you most likely start the trastuzumab during or after chemotherapy?
If recommending trastuzumab plus chemotherapy, would you most likely start the trastuzumab during or after chemotherapy?
If recommending trastuzumab plus chemotherapy, would you most likely start the trastuzumab during or after chemotherapy?
For patients who will be receiving adjuvant trastuzumab, when do you order MUGAs or ECHOs?
paclitaxel/trastuzumab is a reasonable nonprotocol adjuvant treatment option for breast cancer patients with HER2-positive disease.
